Carlyle Group Inc.

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Washington, DC
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
The Carlyle Group Inc., By: /s/ Anne K. Frederick, Corporate Secretary
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Carlyle Group Inc.

Form 4 holding Former 10% owner

ZoomInfo Technologies Inc.

Security class
Class A Common Stock
Shares / value
40,307,862
Estimated value
$2,061,855,973
Report date
15 Aug 2022
Price
$51.15
Ownership
Indirect
Form 4 holding 10%+ Owner

MKS INSTRUMENTS INC

Security class
Common Stock
Shares / value
6,482,732
Estimated value
$713,103,113
Report date
08 May 2023
Price
$110.00
Ownership
Indirect
Form 4 holding 10%+ Owner

SOLENO THERAPEUTICS INC

Security class
Common Stock
Shares / value
1,531,436
Estimated value
$55,874,902
Report date
28 Sep 2023
Price
$36.49
Ownership
Indirect
Form 4 holding 10%+ Owner

Vera Therapeutics, Inc.

Security class
Class A Common Stock
Shares / value
2,960,231
Estimated value
$53,284,158
Report date
17 Aug 2022
Price
$18.00
Ownership
Indirect
Form 4 holding Former 10% Owner

Jasper Therapeutics, Inc.

Security class
Voting Common Stock
Shares / value
1,066,189
Estimated value
$13,807,148
Report date
08 Feb 2024
Price
$12.95
Ownership
Indirect
Form 4 holding 10%+ Owner

Complete Solaria, Inc.

Security class
Common Stock
Shares / value
1,992,427
Estimated value
$3,995,613
Report date
02 Dec 2024
Price
$2.01
Ownership
Indirect
Form 4 holding 10%+ Owner

eFFECTOR Therapeutics, Inc.

Security class
Common Stock
Shares / value
4,822,114
Estimated value
$2,924,612
Report date
01 Aug 2022
Price
$0.6065
Ownership
Indirect
Form 4 holding 10%+ Owner

QuidelOrtho Corp

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
21 Nov 2024
Price
$35.31
Ownership
Indirect
Form 4 holding 10%+ Owner

Medline Inc.

Security class
Class B Common Stock
Shares / value
61,629,472
Estimated value
Report date
05 Mar 2026
Price
Ownership
Indirect
Form 4 holding 10%+ Owner

Medline Inc.

Security class
Common Units of Medline Holdings, LP
Shares / value
61,629,472
Estimated value
Report date
05 Mar 2026
Price
Ownership
Indirect
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding 10%+ Owner

SOLENO THERAPEUTICS INC

Security class
Prefunded Warrants
Shares / value
762,126
Estimated value
Report date
28 Sep 2023
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Complete Solaria, Inc.

Security class
Warrant (right to buy)
Shares / value
0
Estimated value
Report date
18 Jul 2024
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

PPD, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
08 Dec 2021
Price
$47.50
Ownership
Indirect
Form 4 holding 10%+ Owner

SOLENO THERAPEUTICS INC

Security class
Tranche A Warrants
Shares / value
0
Estimated value
Report date
28 Sep 2023
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Vera Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
17 Aug 2022
Price
Ownership
Indirect
Underlying class
Class A Common Stock
Underlying amount

Insider Reports Filed by Carlyle Group Inc.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .